Rapt Therapeutics, Inc. (RAPT)

34.68 +0.62 (+1.82%) USD  |  NASDAQ  |  Jan 14, 14:17
More

Rapt Therapeutics Non-Current Deferred Liabilities (Quarterly)

Non-Current Deferred Liabilities (Quarterly) Chart

View Non-Current Deferred Liabilities (Quarterly) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Liabilities (Quarterly) Benchmarks

View Non-Current Deferred Liabilities (Quarterly) Benchmarks
Start Trial
Replimune Group, Inc. --
Olema Pharmaceuticals, Inc. --
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. --
Theriva Biologics, Inc. Upgrade